Invicta Diagnostic Ltd. IPO Allotment Status: Check Overall Subscription & Steps to Verify Status
The Invicta Diagnostic IPO is expected to be finalised today, on December 4, 2025, and has closed for bidding on December 3, 2025. The shares will be listed on NSE SME, with a tentative listing date of December 8, 2025.
The ₹28.12 crores book build issue opened for subscriptions on December 1, 2025, with a fresh issue of 0.33 crore shares for this amount. The Maharashtra-based Invicta Diagnostic Limited offers pathology and radiology solutions across testing, imaging, and other services through various centres and a central laboratory.
Procedure to Check Invicta Diagnostic Ltd. IPO Allotment Status Online On NSE
- Visit the NSE’s IPO allotment verification status page here.
- Choose “Equity & SME IPO bid details”.
- In Select Symbol, choose “Invicta Diagnostic Limited”.
- Enter your PAN No. and application No.
- Click “Submit”.
Procedure to Check Invicta Diagnostic Ltd. IPO Allotment Status Online On Bigshare Services Pvt. Ltd. (Registrar to the Issue)
- Click here to visit Bigshare Services Pvt. Ltd.’s application status page.
- Select “Invicta Diagnostic Ltd.” in the section for the company.
- Enter any of the following details.
- PAN
- Beneficiary ID
- Application No/CAF No
- Click “Submit” after entering the captcha code.
Invicta Diagnostic Ltd. IPO Details
- The Invicta Diagnostic Limited IPO was a book-building issue of ₹28.12 crores, comprising a fresh issue of 0.33 crore shares worth ₹28.12 crores.
- To be listed on the NSE SME, the Invicta Diagnostic IPO price band is set at ₹80.00 to ₹85.00 per share, with an application lot size of 1,600.
- The minimum investment amount for individual/retail investors is 3,200 shares or ₹2,72,000.00 (based on the upper price). The minimum HNI investment is 4,800 shares or 3 lots, aggregating to ₹4,08,000.
- The book running lead manager is Socradamus Capital Pvt. Ltd., and Bigshare Services Pvt. Ltd. is the issue registrar. The Market Maker of the company is Nikunj Stock Brokers Ltd.
Invicta Diagnostic Ltd. IPO Overall Subscription Status
December 3, 2025, 7:00 p.m
Invicta Diagnostic Ltd. saw an overall subscription of 4.27 times as per the NSE data as of December 3, 2025, 7:00 p.m.
The public issue was subscribed:
- 3.51x by QIB or Qualified Institutional Buyers (ex anchor) investors
- 6.97x by Non-Institutional Investors (NIIs)
- 7.30x by bNII- bids above ₹10L
- 6.27x by sNII- bids below ₹10L
- 3.44x by retail individual investors (RIIs)
Explore other upcoming IPOs on NSE and BSE.
Utilisation of Proceeds
The company proposes to utilise the net proceeds from the issue towards these objectives:
- ₹21.11 crores for funding capital expenditure for the purchase of medical equipment towards the establishment of five new diagnostic centres in Maharashtra
- General Corporate Purposes
About Invicta Diagnostic Ltd.
Founded in January 2021, Invicta Diagnostic Limited offers pathology and radiology solutions. It offers radiology and pathology testing, inclusive of radiology, imaging, and teleradiology, under its PC Diagnostics brand. It has 7 diagnostic centres and a central laboratory throughout Mumbai, Maharashtra. The company has a hub-and-spoke model across the Mumbai Metropolitan Region (MMR), with its flagship hub in Thane West and three additional hubs in Byculla, Marol, and Bhayandar. There are also three spokes in Sewri, Lower Parel, and Kalwa.
Financially, the company reported:
- 90% higher revenue and 30% higher PAT (profit after tax) between the financial year ending with March 31, 2025 and March 31, 2024.
- Assets stood at ₹34.90 crores as of 30 September 2025, while total income was ₹17.08 crores for this period.
- Profit after tax stood at ₹4.08 crore as of this date, with EBITDA at ₹677 crore as of 30 September 2025.
- Total borrowings stood at ₹3.72 crore as of 30 September 2025.
Disclaimer: This news is solely for educational purposes. The securities/investments quoted here are not recommendatory.
To read the RA disclaimer, please click here